Updated on 8 September 2015
Could you briefly outline CMIC's profile and its presence in Japan?
I can proudly admit that CMIC is the first Contract Research Organization in Japan. In 1992, CMIC Group pioneered the CRO business in Japan. More than a decade later, we continue to grow in size, thanks to the support of our customers. When CMIC was established, there were no defined regulations for a CRO, but we worked hard to set-up this establishment as a structured CRO in Japan. We have earned trust and achievement by continuously making small steps by setting study sessions regularly and mediating with the Japanese government. In 1977, the CRO was approved firstly by the revised Pharmaceutical Affairs Act. The approval boosted the CRO industry rapidly and we were also duly recognized and increasingly our business grew and our client list also increased. In 2005, we were the first CRO in Japan to be listed on the First Section of the Tokyo Stock Exchange. And now, our business has stabilized and we have confidently diversified our business into further services like CMO, CSO, Healthcare and IPD.
As a group business how many companies does CMIC hold and what is their focus in the healthcare/pharma vertical?
CMIC group comprises of 21 companies, both in Japan and overseas. The location, size, and business are all different but we work with a uniform mission to serve our clients with complete pharmaceutical services.
Could you elaborate on the company's range of services?